Pharming Group N.V. (PHAR) — Institutional Holders, Q2 2026
18 institutional investment managers reported a PHAR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.3M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PHAR in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Crossmark GlobalNew · +12,463 sh+$173.1K
- CITADEL ADVISORSAdded · +1,783 sh+$24.8K
- Silver Grove Financial GroupNew · +1,071 sh+$14.9K
- Integrated Wealth ConceptsNew · +380 sh+$5.3K
- Optiver Holding B.V.New · +305 sh+$4.2K
Biggest sellers
- Silverberg Bernstein Capital ManagementTrimmed · -3,200 sh-$44.4K
- SmartHarvest PortfoliosTrimmed · -382 sh-$5.3K
- Larson Financial GroupTrimmed · -336 sh-$4.7K
- OSAICTrimmed · -112 sh-$1.6K
- BNP PARIBAS FINANCIAL MARKETSTrimmed · -100 sh-$1.4K
PHAR 13F holders ranked 1–18 of 18
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | MAC Alpha Capital Management#1 · 2,148,144 sh | 2,148,144 | $2.9M | 1.36% | New |
| 2 | Silverberg Bernstein Capital Management#2 · 41,547 sh | 41,547 | $577.1K | — | -7.2% |
| 3 | Crossmark Global#3 · 12,463 sh | 12,463 | $169.0K | — | New |
| 4 | CITADEL ADVISORS#4 · 11,972 sh | 11,972 | $162.3K | 0.00% | +17.5% |
| 5 | MORGAN STANLEY#5 · 11,500 sh | 11,500 | $159.7K | 0.00% | +0.1% |
| 6 | SmartHarvest Portfolios#6 · 10,415 sh | 10,415 | $144.7K | — | -3.5% |
| 7 | Knoll Capital Management#7 · 4,091 sh | 4,091 | $56.8K | 0.03% | +0.8% |
| 8 | Silver Grove Financial Group#8 · 1,071 sh | 1,071 | $14.9K | <0.01% | New |
| 9 | Nalls Sherbakoff Group#9 · 870 sh | 870 | $12.1K | <0.01% | 0.0% |
| 10 | Global Retirement Partners#10 · 456 sh | 456 | $6.3K | <0.01% | — |
| 11 | Integrated Wealth Concepts#11 · 380 sh | 380 | $5.3K | 0.00% | New |
| 12 | BNP PARIBAS FINANCIAL MARKETS#12 · 300 sh | 300 | $4.2K | 0.00% | -25.0% |
| 13 | Optiver Holding B.V.#13 · 305 sh | 305 | $4.1K | 0.00% | New |
| 14 | NewEdge Advisors#14 · 187 sh | 187 | $2.6K | 0.00% | New |
| 15 | UBS Group AG#15 · 39 sh | 39 | $542.00 | 0.00% | New |
| 16 | OSAIC#16 · 16 sh | 16 | $222.00 | 0.00% | -87.5% |
| 17 | Larson Financial Group#17 · 7 sh | 7 | $97.00 | 0.00% | -98.0% |
| 18 | Caitong International Asset Management , Ltd#18 · 1 sh | 1 | $14.00 | 0.00% | New |
Funds that sold out of PHAR in Q2 2026 (3)
Held PHAR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| EverSource Wealth Advisors1,440 sh | 1,440 | $7.6K |
| Stone House Investment Management79 sh | 79 | $1.3K |
| Cornerstone Financial Management32 sh | 32 | $532.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.